Adam Schreiber, DO
Pain Medicine · Mount Laurel, NJNPI 1831313352
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 370 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 24.5% of the total.
Across 370 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$1K
- Scilex Pharmaceuticals Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$911
- Abbott$316
- Amgen$259
- Si-bone, Inc.$191
- plus $1K from 22 others
What the payments were for
- Food & beverage$5,360100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 86 | $1,314 |
| Scilex Pharmaceuticals Inc. | 86 | $1,025 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 81 | $911 |
| Abbott | 20 | $316 |
| Amgen | 26 | $259 |
| Si-bone, Inc. | 6 | $191 |
| GRT US Holding, Inc. | 4 | $166 |
| Valinor Pharma, LLC | 8 | $127 |
| IBSA Pharma Inc. | 7 | $104 |
| SPR Therapeutics, Inc | 2 | $96 |
| Saluda Medical Americas, Inc. | 3 | $93 |
| Vertos Medical, Inc. | 2 | $83 |
| AbbVie | 4 | $77 |
| Vertex | 3 | $75 |
| Forte Bio-pharma LLC | 4 | $65 |
| Almatica Pharma LLC | 4 | $62 |
| Avanos Medical | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 4 | $55 |
| Pfizer | 3 | $53 |
| Protega Pharmaceutials Inc | 3 | $45 |
| Redhill Biopharma Inc. | 3 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Globus Medical | 1 | $34 |
| Convatec Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$125
How this compares
$5,360 in reported general payments places this provider in the 80th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 21 | $55,650 |
| BelbucaBuprenorphine Hcl | 79 | $50,062 |
| OxycontinOxycodone Hcl | 54 | $20,199 |
| ZtlidoLidocaine | 28 | $19,588 |
| Lidocaine | 121 | $17,579 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 500 | $13,296 |
| Oxycodone Hcl | 652 | $11,919 |
| MovantikNaloxegol Oxalate | 28 | $10,959 |
| SymproicNaldemedine Tosylate | 21 | $9,779 |
| Buprenorphine | 54 | $9,155 |
| Diclofenac Sodium | 112 | $8,770 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 212 | $5,831 |
| Xtampza ErOxycodone Myristate | 16 | $5,268 |
| Gabapentin | 447 | $5,027 |
| Hysingla ErHydrocodone Bitartrate | 15 | $4,912 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $911 | $55,65021 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $1,314 | $55,33095 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,025 | $19,58828 claims |
| Redhill Biopharma Inc.Movantik | $39 | $10,95928 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Mount Laurel
- Matthew LesneskiMount Laurel$47K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
- Dipan PatelClifton$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.